Sanofi
SNY
$49.36
Share price
5.90%
Change (1 day)
-13.68%
Change (1 year)
Categories
Sanofi is a French pharmaceutical company created in 2004 by the merger of Sanofi-Synthélabo and Aventis. With sales of EUR 36.1 billion in 2019 and more than 100,000 employees worldwide, Sanofi is one of the largest pharmaceutical companies in the world in terms of sales.
P/S ratio for Sanofi (SNY)
P/S ratio as of April 2024 (TTM): 2.45
According to Sanofi's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.44688. At the end of 2023 the company had a P/S ratio of 2.48.
P/S ratio history for Sanofi from 2003 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 2.48 | -2.9% |
| 2022 | 2.55 | -7.54% |
| 2021 | 2.76 | -9.87% |
| 2020 | 3.06 | 2.27% |
| 2019 | 2.99 | 16.29% |
| 2018 | 2.57 | -0.82% |
| 2017 | 2.59 | -4.98% |
| 2016 | 2.73 | -9.71% |
| 2015 | 3.02 | 10.67% |
| 2014 | 2.73 | -14.23% |
| 2013 | 3.19 | 17.7% |
| 2012 | 2.71 | 31.69% |
| 2011 | 2.06 | 3.88% |
| 2010 | 1.98 | -17.66% |
| 2009 | 2.40 | 21.9% |
| 2008 | 1.97 | -34.58% |
| 2007 | 3.01 | -9.92% |
| 2006 | 3.35 | -5.97% |
| 2005 | 3.56 | -38.72% |
| 2004 | 5.81 | 0.13% |
| 2003 | 5.80 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 3.85 | 57.25% | 🇺🇸 USA |
 Novartis NVS | 3.96 | 61.93% | 🇨🇭 Switzerland |
 Pfizer PFE | 2.54 | 3.93% | 🇺🇸 USA |
 Novo Nordisk NVO | 16.6 | 579.78% | 🇩🇰 Denmark |
 Abbott Laboratories ABT | 4.62 | 88.99% | 🇺🇸 USA |
 Eli Lilly LLY | 20.4 | 733.74% | 🇺🇸 USA |
 Merck MRK | 5.51 | 125.11% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 2.20 | -10.08% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 2.21 | -9.75% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | 0.9471 | -61.29% | 🇮🇱 Israel |